Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LMT vs GSK✓SelectedUSD · GSKLMT vs GSK performance historyLatest closeAs of-1.11%11/20
Stock and ETF performance explorer

LMT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+38.0%
GSK return
+53.4%
Excess return
-15.3%
Maximum drawdown
-31.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-0.1%-1.0%-1.1%
7D-5.1%-5.3%+0.2%-4.4%
30D+2.5%-3.7%+6.2%+3.0%
3M-0.4%-7.3%+6.8%+0.5%
6M+9.6%-4.2%+13.8%+10.1%
YTD+19.0%+0.9%+18.2%+18.6%
1Y+23.9%+7.3%+16.6%+22.5%
3Y+38.0%+52.7%-14.7%+23.1%
All+38.0%+53.4%-15.3%+23.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling